Bridget E. Bunner

Array ( [id] => 322293 [patent_doc_number] => 07517523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Anti-MIF antibodies' [patent_app_type] => utility [patent_app_number] => 10/462751 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 31329 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517523.pdf [firstpage_image] =>[orig_patent_app_number] => 10462751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725481 [patent_doc_number] => 20030207793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Secreted alpha-helical protein - 32' [patent_app_type] => new [patent_app_number] => 10/461093 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17938 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207793.pdf [firstpage_image] =>[orig_patent_app_number] => 10461093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7365356 [patent_doc_number] => 20040005704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Low oxygen culturing of central nervous system progenitor cells' [patent_app_type] => new [patent_app_number] => 10/462896 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19119 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005704.pdf [firstpage_image] =>[orig_patent_app_number] => 10462896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716352 [patent_doc_number] => 07053180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Isolated islet beta-cell two-pore domain potassium channel' [patent_app_type] => utility [patent_app_number] => 10/459190 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23335 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053180.pdf [firstpage_image] =>[orig_patent_app_number] => 10459190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730729 [patent_doc_number] => 20030186919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Regulation of human sodium-dependent monoamine transporter' [patent_app_type] => new [patent_app_number] => 10/398119 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18148 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186919.pdf [firstpage_image] =>[orig_patent_app_number] => 10398119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674435 [patent_doc_number] => 20040127683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Transporters and ion channels' [patent_app_type] => new [patent_app_number] => 10/311624 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40950 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127683.pdf [firstpage_image] =>[orig_patent_app_number] => 10311624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678523 [patent_doc_number] => 20030228664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/439249 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 64273 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228664.pdf [firstpage_image] =>[orig_patent_app_number] => 10439249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770370 [patent_doc_number] => 20030216310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Transporters and ion channels' [patent_app_type] => new [patent_app_number] => 10/297022 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48553 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216310.pdf [firstpage_image] =>[orig_patent_app_number] => 10297022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 589021 [patent_doc_number] => 07439332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells' [patent_app_type] => utility [patent_app_number] => 10/512109 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 18083 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439332.pdf [firstpage_image] =>[orig_patent_app_number] => 10512109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530410 [patent_doc_number] => 07887796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Method of inhibiting collagen formation by VDUP1 inhibition' [patent_app_type] => utility [patent_app_number] => 10/512518 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 54 [patent_no_of_words] => 26895 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/887/07887796.pdf [firstpage_image] =>[orig_patent_app_number] => 10512518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404817 [patent_doc_number] => 20040175698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Regulation of human latrophilin-like g protein-coupled receptor' [patent_app_type] => new [patent_app_number] => 10/221159 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20371 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175698.pdf [firstpage_image] =>[orig_patent_app_number] => 10221159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846988 [patent_doc_number] => 20030166155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/419190 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23773 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166155.pdf [firstpage_image] =>[orig_patent_app_number] => 10419190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769938 [patent_doc_number] => 20030215878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Novel G protein-coupled purinergic receptor, GAVE17' [patent_app_type] => new [patent_app_number] => 10/408572 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33950 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215878.pdf [firstpage_image] =>[orig_patent_app_number] => 10408572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367210 [patent_doc_number] => 20040006018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Cardiotrophin and uses therefor' [patent_app_type] => new [patent_app_number] => 10/407303 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 51996 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006018.pdf [firstpage_image] =>[orig_patent_app_number] => 10407303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967057 [patent_doc_number] => 20050233954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Use of resistin to treat hematopoietic disorders' [patent_app_type] => utility [patent_app_number] => 10/509767 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233954.pdf [firstpage_image] =>[orig_patent_app_number] => 10509767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399732 [patent_doc_number] => 20040023341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Anti-IL-TIF antibodies and methods of using in inflammation' [patent_app_type] => new [patent_app_number] => 10/395741 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 65428 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023341.pdf [firstpage_image] =>[orig_patent_app_number] => 10395741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440499 [patent_doc_number] => 20040185450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'MCP-1 mutant proteins, antibodies, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/393804 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33809 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185450.pdf [firstpage_image] =>[orig_patent_app_number] => 10393804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367216 [patent_doc_number] => 20040092441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Tyrosine kinase modulators' [patent_app_type] => new [patent_app_number] => 10/297382 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9286 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092441.pdf [firstpage_image] =>[orig_patent_app_number] => 10297382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726907 [patent_doc_number] => 20060057667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/506513 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 23431 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057667.pdf [firstpage_image] =>[orig_patent_app_number] => 10506513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333131 [patent_doc_number] => 20040131585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury' [patent_app_type] => new [patent_app_number] => 10/220554 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 17579 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10220554 [rel_patent_id] =>[rel_patent_doc_number] =>)